Literature DB >> 22992702

Analysis of the impact of intravenous LH pulses versus continuous LH infusion on testosterone secretion during GnRH-receptor blockade.

Johannes D Veldhuis1, Peter Y Liu, Paul Y Takahashi, Suanne M Weist, Jean R Wigham.   

Abstract

Gonadotrophin-releasing hormone (GnRH) pulsatility is required for optimal luteinizing hormone (LH) secretion, but whether LH pulsatility is required for physiological testosterone (T) secretion is not known. To test the postulate that pulses of recombinant human (rh) LH stimulate greater T secretion than continuous infusion of the same dose, a potent selective GnRH antagonist was administered overnight to 19 healthy men ages 18-49 yr. Subjects then received saline or rhLH intravenously continuously or as 6-min pulses intravenously every 1 or 2 h at the same total dose. Blood was sampled every 10 min for 10 h to quantify T responses. For the four interventions, the descending rank order of mean LH and mean T concentrations was 1-h = 2-h rhLH pulses > continuous rhLH > saline (P < 10(-3)). Plateau LH and T concentrations correlated positively (R(2) = 0.943, P = 0.029) as did LH concentrations and LH half-lives (R(2) = 0.962, P = 0.019). Percentage pulsatile T secretion assessed by deconvolution analysis (Keenan DM, Takahashi PY, Liu PY, Roebuck PD, Nehra AX, Iranmanesh A, Veldhuis JD. Endocrinology 147: 2817-2828, 2006) was the highest (P = 0.019), and half-time to attain peak T concentrations was the shortest (P < 10(-6)), for 1-h rhLH pulses. Approximate entropy (a pattern-regularity measure) revealed more orderly T secretion for 1- than 2-h rhLH pulses (P = 0.0076). Accordingly, a pulsatile LH signal, while not obligatory to maintain mean T concentrations, controls the mean plasma LH concentration and determines quantifiable patterns of T secretion. These data introduce the question whether blood T patterns in turn supervise distinctive target-tissue responses.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22992702      PMCID: PMC3517669          DOI: 10.1152/ajpregu.00314.2012

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  56 in total

1.  Development of immunoturbidimetric assays for fourteen human serum proteins on the Hitachi 912.

Authors:  Thomas B Ledue; Marilyn F Collins; Robert F Ritchie
Journal:  Clin Chem Lab Med       Date:  2002-05       Impact factor: 3.694

2.  Differential effects of gonadotropin-releasing hormone (GnRH) pulse frequency on gonadotropin subunit and GnRH receptor messenger ribonucleic acid levels in vitro.

Authors:  U B Kaiser; A Jakubowiak; A Steinberger; W W Chin
Journal:  Endocrinology       Date:  1997-03       Impact factor: 4.736

3.  Recombinant human luteinizing hormone (LH) to support recombinant human follicle-stimulating hormone (FSH)-induced follicular development in LH- and FSH-deficient anovulatory women: a dose-finding study. The European Recombinant Human LH Study Group.

Authors: 
Journal:  J Clin Endocrinol Metab       Date:  1998-05       Impact factor: 5.958

4.  Older males secrete luteinizing hormone and testosterone more irregularly, and jointly more asynchronously, than younger males.

Authors:  S M Pincus; T Mulligan; A Iranmanesh; S Gheorghiu; M Godschalk; J D Veldhuis
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

5.  Adrenocorticotropin stimulation of aldosterone: prolonged continuous versus pulsatile infusion.

Authors:  E W Seely; P R Conlin; G A Brent; R G Dluhy
Journal:  J Clin Endocrinol Metab       Date:  1989-11       Impact factor: 5.958

6.  High dose gonadotrophin-releasing hormone antagonist (ganirelix) may prevent ovarian hyperstimulation syndrome caused by ovarian stimulation for in-vitro fertilization.

Authors:  D de Jong; N S Macklon; B M Mannaerts; H J Coelingh Bennink; B C Fauser
Journal:  Hum Reprod       Date:  1998-03       Impact factor: 6.918

7.  Disparate serum free testosterone concentrations and degrees of hypothalamo-pituitary-luteinizing hormone suppression are achieved by continuous versus pulsatile intravenous androgen replacement in men: a clinical experimental model of ketoconazole-induced reversible hypoandrogenemia with controlled testosterone add-back.

Authors:  A D Zwart; A Iranmanesh; J D Veldhuis
Journal:  J Clin Endocrinol Metab       Date:  1997-07       Impact factor: 5.958

8.  Amplified nocturnal luteinizing hormone (LH) secretory burst frequency with selective attenuation of pulsatile (but not basal) testosterone secretion in healthy aged men: possible Leydig cell desensitization to endogenous LH signaling--a clinical research center study.

Authors:  T Mulligan; A Iranmanesh; S Gheorghiu; M Godschalk; J D Veldhuis
Journal:  J Clin Endocrinol Metab       Date:  1995-10       Impact factor: 5.958

9.  Effects of continuous and pulsatile administration of pituitary rat thyrotropin and recombinant human thyrotropin in a chronically cannulated rat.

Authors:  H Leitolf; M W Szkudlinski; C Hoang-Vu; N R Thotakura; A von zur Mühlen; G Brabant; B D Weintraub
Journal:  Horm Metab Res       Date:  1995-04       Impact factor: 2.936

10.  Endocrine effects and pharmacokinetic characteristics of a potent new gonadotropin-releasing hormone antagonist (Ganirelix) with minimal histamine-releasing properties: studies in postmenopausal women.

Authors:  J Rabinovici; P Rothman; S E Monroe; C Nerenberg; R B Jaffe
Journal:  J Clin Endocrinol Metab       Date:  1992-11       Impact factor: 5.958

View more
  4 in total

1.  Challenges and methodology for testing young healthy women in physiological studies.

Authors:  Nina S Stachenfeld; Hugh S Taylor
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-02-25       Impact factor: 4.310

2.  Premenstrual Dysphoric Disorder Symptoms Following Ovarian Suppression: Triggered by Change in Ovarian Steroid Levels But Not Continuous Stable Levels.

Authors:  Peter J Schmidt; Pedro E Martinez; Lynnette K Nieman; Deloris E Koziol; Karla D Thompson; Linda Schenkel; Paul G Wakim; David R Rubinow
Journal:  Am J Psychiatry       Date:  2017-04-21       Impact factor: 18.112

3.  Familial Longevity Is Not Associated with Major Differences in the Hypothalamic-Pituitary-Gonadal Axis in Healthy Middle-Aged Men.

Authors:  Evie van der Spoel; Ferdinand Roelfsema; Steffy W Jansen; Abimbola A Akintola; Bart E Ballieux; Christa M Cobbaert; Gerard J Blauw; P Eline Slagboom; Rudi G J Westendorp; Hanno Pijl; Diana van Heemst
Journal:  Front Endocrinol (Lausanne)       Date:  2016-11-09       Impact factor: 5.555

4.  Relationships Between 24-hour LH and Testosterone Concentrations and With Other Pituitary Hormones in Healthy Older Men.

Authors:  Evie van der Spoel; Ferdinand Roelfsema; Diana van Heemst
Journal:  J Endocr Soc       Date:  2021-04-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.